To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

GI Cancers Alliance

The GI Cancers Alliance works to raise awareness, provide education and advocate to prevent, treat and cure gastrointestinal cancers through a collaboration between advocacy groups, industry and institutional partners. Its vision is to create a stronger, more unified voice to fight gastrointestinal cancers, which collectively make up the most common and deadliest type of cancers. The patient voice is central in addressing unmet needs in screening, awareness and treatment. View a list of member organizations.
There can be many benefits for patients with gastrointestinal cancers, as well as their loved ones, to undergo genetic testing.
An expert describes what an interventional clinical trial is.
Clinical trials are essential in improving treatment in the world of oncology, especially for rare cancers.
Two women discuss their experience in cancer caregiving, while giving advice to others.
A patient advocate goes through the three steps of genetic testing.
Reflecting back on what he learned as a caregiver for his son, Tom Stockwell discusses how he provides assistance to others as a patient navigator for the Fibrolamellar Cancer Foundation. Stockwell further explains why advocacy and research are so important in rare diseases.
Tom Stockwell, whose son was diagnosed with advanced fibrolamellar hepatocellular carcinoma, and John Hopper, president of the Fibrolamellar Cancer Foundation and co-chair of the GI Cancers Alliance, remark on the importance of taking a proactive role when making treatment decisions with healthcare professionals and emphasize the value in establishing a survivorship care plan.
Tom Stockwell explains how he found information and resources following the diagnosis of his son’s advanced fibrolamellar hepatocellular carcinoma, an ultra-rare liver cancer.
Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.
Blue Faery, the Adrienne Wilson Liver Cancer Association, is a nonprofit corporation founded in 2002, with the intent to prevent, treat and cure primary liver cancer – particularly HCC – through research, education and advocacy. Its name, inspired by Adrienne, has a unique background.
National non-profit begins a new chapter revealing new name, logo, and inclusive mission.
A free two-day workshop will train people who want to raise awareness of liver diseases and influence public health policy to address their concerns.
Andrea J. Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, offers advice for patients with liver cancer. Wilson started the foundation after her younger sister, Adrienne, died of liver cancer.
Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.
A survey about life after GI cancer has sparked the creation of specialized survivorship care plan.
In this CURE Connections® program, Philippa Cheetham, MD, interviews key thought leaders of the GI Cancers Alliance, a coalition of organizations that have joined together to raise awareness, provide education, and accelerate the research and development of treatments in the area of gastrointestinal cancers. Craig Lustig (The Ruesch Center for the Cure of GI Cancers), Martha Raymond (Michael’s Mission, The Raymond Foundation), and John Hopper (Fibrolamellar Cancer Foundation) highlight services and resources that are provided through the alliance to help patients and loved ones better navigate through gastrointestinal cancer.
In this special CURE Connections® program, broadcast live at The Ruesch Center for the Cure of GI Cancers, Philippa Cheetham, MD, Martha Raymond (Michael’s Mission, The Raymond Foundation), Craig Lustig (The Ruesch Center for the Cure of GI Cancers), and Paula Rothenberg (Hope Connections for Cancer Support) discuss results of a brief survey, conducted by the GI Cancers Alliance, that have helped advocates to better understand the unmet needs of gastrointestinal cancer patients and survivors. The panelists highlight some of the most critical issues that need to be addressed, and remark on the importance of establishing survivorship-care plans that are unique to the patient. Members of the audience also have an opportunity to share personal encounters, provide insight, and ask questions to the expert panelists.

Sign In

Not a member? Sign up now!
Continue without login